Health News
FDA Approves Pain Reliever Abstral for Cancer Patients
The FDA has approved the use of Abstral for additional pain relief in cancer patients. The drug is an immediate release medication designed to help individuals already on regular opioid pain treatment.
Googling Gamble: Health News in the Information Age
More Americans are tuning to the Internet to get their health and medical news, a recent study shows. But is the information they're getting valuable?
Bad for the Bones
Past studies have established links between anti-epileptic drugs and bone density loss . Now, new research indicates that specific anti-epileptic drugs correspond to an increased risk of bone fractures in people 50 years of age and older.
Affordable Care Act Predictions: It's a Numbers Game
A report from the Robert Wood Johnson Foundation (RWJF) and the Urban Institute believes that if the Patient Protection and Affordable Care Act (ACA) is fully implemented, it will insure 27.8 million previously uninsured adults.
Affordable Care Act in Action
A number of provisions from the Patient Protection and Affordable Care Act (ACA) took effect this New Years Day. Meanwhile, Republicans are mounting their offense to repeal the law.
Obesity Costs Take the Cake
Are you at your optimum weight? If not, don't fret. Knowledge is power, and the more you know, the more you can do to make 2011 your Healthy Weight Year.
Television Kills
You already know that exercise improves your heart health, but apparently the amount you exercise might not matter if you are spending too much of your day watching television.
TB Therapy Risky for Elderly
Tuberculosis (TB) affects one third of the world's population. In some, the disease is latent, meaning it is inactive and non-contagious.
Nevermind Mindfulness
Mindful meditation -- a combination of gentle yoga maneuvers and meditation -- doesn't appear to help those with the chronic pain condition known as fibromyalgia.
Would You Pay for a Crystal Ball?
If you could take a test to find out if disease is in your future, would you take it? Researchers at Tufts Medical Center set out to answer that question.